McMillan Office’s Stryker SYK Stock Holding History

McMillan Office’s Portfolio SYK Stock Details SYK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.56M	Hold	4,945	–	–	0.18%	64
2026 Q1	$1.62M	Hold	4,945	–	–	0.21%	60
2025 Q4	$1.74M	Buy	+4,945	New	+$1.8M	0.21%	59

Other funds holding SYK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Greenleaf Trust Kalamazoo, Michigan $10.4B AUM 0.97% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

McMillan Office's SYK Position: Q2 2026 in Review

McMillan Office held its Stryker (SYK) position steady in Q2 2026 at 4,945 shares worth $1.56M. The position accounts for 0.18% of the portfolio, ranked #64.

McMillan Office first reported a position in SYK in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.74M in Q4 2025. 2,254 funds tracked by Wall St. Rank hold SYK as of Q2 2026.

McMillan Office held 4,945 shares of Stryker worth $1.56M as of Q2 2026.
McMillan Office left its Stryker share count unchanged in Q2 2026.
Stryker made up 0.18% of McMillan Office's portfolio in Q2 2026, its #64 holding.
McMillan Office first reported a position in Stryker in Q4 2025 and has held it in 3 quarters since.
McMillan Office's Stryker position peaked at $1.74M in Q4 2025.
2,254 funds tracked by Wall St. Rank held Stryker as of Q2 2026.

Based on McMillan Office's 13F filing for Q2 2026, filed 13 Aug 2026.